Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Cisneros IE"'
Autor:
Fongsaran C; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA., Dineley KT; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA.; Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA., Paessler S; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA., Cisneros IE; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA.; Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA.
Publikováno v:
Pathogens (Basel, Switzerland) [Pathogens] 2024 May 09; Vol. 13 (5). Date of Electronic Publication: 2024 May 09.
Autor:
Fongsaran C; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX, USA., Jirakanwisal K; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX, USA., Peng BH; Department of Neurobiology, University of Texas Medical Branch, Galveston, TX, USA., Fracassi A; Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA., Taglialatela G; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA., Dineley KT; Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA.; Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA., Paessler S; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Cisneros IE; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.; Neuroinfectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Brain, behavior, & immunity - health [Brain Behav Immun Health] 2024 Apr 24; Vol. 38, pp. 100780. Date of Electronic Publication: 2024 Apr 24 (Print Publication: 2024).
Autor:
Ezeomah C; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; Galveston National Laboratory, Institute of Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; Population Health Sciences, Weill Cornell Medical College of Cornell University, 402 East 67th Street, New York, NY 10065, USA., Fongsaran C; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; Galveston National Laboratory, Institute of Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; NeuroInfectious Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Persons AL; Physician Assistant Studies, Rush University Medical Center, Chicago, IL 60612, USA.; Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL 60612, USA., Napier TC; Center for Compulsive Behavior and Addiction, Rush University Medical Center, Chicago, IL 60612, USA.; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA., Cisneros IE; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; Galveston National Laboratory, Institute of Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; NeuroInfectious Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA.
Publikováno v:
Cells [Cells] 2022 Aug 04; Vol. 11 (15). Date of Electronic Publication: 2022 Aug 04.
Autor:
Merritt CR; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States., Cisneros IE; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States., Covarrubias-Zambrano O; Department of Chemistry, Kansas State University, Manhattan, KS, United States.; Department of Cancer Biology, The University of Kansas Cancer Center, Kansas City, MO, United States., Stutz SJ; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States., Motamedi M; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States.; Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, United States., Bossmann SH; Department of Chemistry, Kansas State University, Manhattan, KS, United States.; Department of Cancer Biology, The University of Kansas Cancer Center, Kansas City, MO, United States., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Jun 27; Vol. 13, pp. 893828. Date of Electronic Publication: 2022 Jun 27 (Print Publication: 2022).
Autor:
Cisneros IE; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: ircisner@utmb.edu., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2021 Oct 15; Vol. 198, pp. 108766. Date of Electronic Publication: 2021 Aug 26.
Autor:
Cisneros IE; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. ircisner@utmb.edu.; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. ircisner@utmb.edu.; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. ircisner@utmb.edu., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Jan; Vol. 46 (1), pp. 247.
Autor:
Cisneros IE; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, United States., Ghorpade A; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, United States., Borgmann K; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, United States.
Publikováno v:
Frontiers in neurology [Front Neurol] 2020 Nov 25; Vol. 11, pp. 593146. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Autor:
Ezeomah C; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Stutz SJ; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Fox RG; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Bukreyeva N; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Dineley KT; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Department of Neurology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Paessler S; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA., Cisneros IE; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77550, USA. Electronic address: ircisner@utmb.edu.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2020 Jul; Vol. 87, pp. 725-738. Date of Electronic Publication: 2020 Mar 09.
Autor:
Dimet AL; Center for Addiction Research, University of Texas Medical Branch; Institute for Translational Sciences, University of Texas Medical Branch; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch., Cisneros IE; Center for Addiction Research, University of Texas Medical Branch; Department of Neurology, University of Texas Medical Branch; Department of Pathology, University of Texas Medical Branch., Fox RG; Center for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch., Stutz SJ; Center for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch., Anastasio NC; Center for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch; Department of Pharmacology and Toxicology, University of Texas Medical Branch., Dineley KT; Center for Addiction Research, University of Texas Medical Branch; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch; Department of Neurology, University of Texas Medical Branch; ktdinele@utmb.edu.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2018 Jun 18 (136). Date of Electronic Publication: 2018 Jun 18.
Autor:
Cisneros IE; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Department of Neurology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. Electronic address: ircisner@utmb.edu., Erdenizmenli M; School of Medicine, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. Electronic address: meerdeni@utmb.edu., Cunningham KA; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. Electronic address: kcunning@utmb.edu., Paessler S; Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. Electronic address: slpaessl@utmb.edu., Dineley KT; Center for Addiction Research, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Department of Neurology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77550, USA. Electronic address: ktdinele@utmb.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2018 Jun; Vol. 135, pp. 431-443. Date of Electronic Publication: 2018 Mar 23.